CellCentric, a clinical-stage biotechnology company fighting blood cancer has onboarded Celia Economides as new CFO and Chief ...

Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial. This is an ASCO ...

Note: Differences in patient/disease characteristics among groups (FL1-2, FL3A, FL3B and FL/DLBCL respectively) were analyzed using Fisher’s exact test for discrete variables and the Kruskal-Wallis H ...

The Department of Medicine's Rheumatology Division is a world leader in the clinical care of patients with some of the most complex of all medical diseases, including rheumatoid arthritis, lupus, ...